Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > Revenue estimates for willow

<< Previous

Bullboard Posts

Next >>

Comment by JPJune2020on Aug 15, 2021 11:49pm

208 Views

Post# 33708228

RE:Revenue estimates for willow

Appreciate your posts, but I do feel like WLLW's product has a hard time to sell. There are competitors out there is using the same method to make the same compound. regards of what WLLW's updates about multiple contracts. It doesn't reflect on their ERs. So they need to find buyers ASAP.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?